RCT of Adjunctive Curcumin and the Meru Health Program
RCT of Adjunctive Curcumin and the Meru Health Program
NCT ID: NCT04744545 Phase: NA Status: COMPLETED Enrollment: 60 Completion: 2021-12-30
Conditions
Depression
Interventions
Meru Health Program, Curcumin
Summary
This is a randomized controlled trial (RCT) to compare the Meru Health Program plus adjunctive curcumin (MHP-CUR) versus Meru Health Program only (MHP-ONLY) for adults with depression. Meru Health is a 12-week integrative treatment program based on several evidence-based practices and overseen by licensed clinical therapists that is delivered via a Smartphone app. The primary objective of the study is to determine the feasibility, initial efficacy (depressive symptoms), and potential harms of taking adjunctive curcumin supplementation during the 12-week MHP among adults with depression. Secondary objectives include comparing changes in inflammation biomarkers, anxiety, worker productivity, and burnout that occur during the program between those in MHP-CUR and MHP-ONLY.
Primary Outcome
Depression